Tens of thousands of people will participate in phase III of COVID-19 vaccine trials

Several tens of thousands of people are planned to be involved in the third - post-registration - stage of studies of the coronavirus vaccine developed by the Gamalei National Research Center (NIC) for Epidemiology and Microbiology